首页 > 最新文献

JBMR Plus最新文献

英文 中文
The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD 膳食纤维菊粉可延缓慢性肾脏病大鼠模型中慢性肾脏病-矿物质骨病(CKD-MBD)的进展
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-12-07 DOI: 10.1002/jbm4.10837
Annabel Biruete, Neal X. Chen, Corinne E. Metzger, Shruthi Srinivasan, Kalisha O'Neill, Paul B. Fallen, Austin Fonseca, Hannah E. Wilson, Henriette de Loor, Pieter Evenepoel, Kelly S. Swanson, Matthew R. Allen, Sharon M. Moe

Chronic kidney disease (CKD)–mineral bone disorder (CKD-MBD) leads to fractures and cardiovascular disease. Observational studies suggest beneficial effects of dietary fiber on both bone and cardiovascular outcomes, but the effect of fiber on CKD-MBD is unknown. To determine the effect of fiber on CKD-MBD, we fed the Cy/+ rat with progressive CKD a casein-based diet of 0.7% phosphate with 10% inulin (fermentable fiber) or cellulose (non-fermentable fiber) from 22 weeks to either 30 or 32 weeks of age (~30% and ~15% of normal kidney function; CKD 4 and 5). We assessed CKD-MBD end points of biochemistry, bone quantity and quality, cardiovascular health, and cecal microbiota and serum gut-derived uremic toxins. Results were analyzed by two-way analysis of variance (ANOVA) to evaluate the main effects of CKD stage and inulin, and their interaction. The results showed that in CKD animals, inulin did not alter kidney function but reduced the increase from stage 4 to 5 in serum levels of phosphate and parathyroid hormone, but not fibroblast growth factor-23 (FGF23). Bone turnover and cortical bone parameters were similarly improved but mechanical properties were not altered. Inulin slowed progression of aorta and cardiac calcification, left ventricular mass index, and fibrosis. To understand the mechanism, we assessed intestinal microbiota and found changes in alpha and beta diversity and significant changes in several taxa with inulin, together with a reduction in circulating gut derived uremic toxins such as indoxyl sulfate and short-chain fatty acids. In conclusion, the addition of the fermentable fiber inulin to the diet of CKD rats led to a slowed progression of CKD-MBD without affecting kidney function, likely mediated by changes in the gut microbiota composition and lowered gut-derived uremic toxins. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.

慢性肾脏疾病(CKD) -矿物质骨紊乱(CKD‐MBD)导致骨折和心血管疾病。观察性研究表明,膳食纤维对骨骼和心血管结果都有有益的影响,但纤维对CKD - MBD的影响尚不清楚。为了确定纤维对CKD - MBD的影响,我们在22周龄至30或32周龄期间(正常肾功能的~30%和~15%),给患有进行性CKD的Cy/+大鼠喂食含有0.7%磷酸盐和10%菊粉(可发酵纤维)或纤维素(不可发酵纤维)的酪蛋白饲粮。我们评估了CKD - MBD的生化终点、骨骼数量和质量、心血管健康、盲肠微生物群和血清肠道源性尿毒症毒素。结果通过双向方差分析(ANOVA)来评估CKD分期和菊粉的主要影响及其相互作用。结果显示,在CKD动物中,菊粉没有改变肾功能,但降低了从4期到5期血清磷酸盐和甲状旁腺激素水平的升高,但对成纤维细胞生长因子- 23 (FGF23)没有影响。骨转换和骨皮质参数同样得到改善,但力学性能没有改变。菊粉减缓了主动脉和心脏钙化、左心室质量指数和纤维化的进展。为了了解这一机制,我们评估了肠道微生物群,发现在菊粉的作用下,α和β多样性发生了变化,几个分类群发生了显著变化,同时循环肠道来源的尿毒症毒素(如硫酸吲哚酚和短链脂肪酸)减少。总之,在CKD大鼠的饮食中添加可发酵纤维菊粉可以减缓CKD - MBD的进展,而不影响肾功能,可能是通过改变肠道微生物群组成和降低肠道源性尿毒症毒素介导的。©2023作者。JBMR Plus由Wiley期刊有限责任公司代表美国骨与矿物研究协会出版。
{"title":"The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD-MBD) in a Rat Model of CKD","authors":"Annabel Biruete,&nbsp;Neal X. Chen,&nbsp;Corinne E. Metzger,&nbsp;Shruthi Srinivasan,&nbsp;Kalisha O'Neill,&nbsp;Paul B. Fallen,&nbsp;Austin Fonseca,&nbsp;Hannah E. Wilson,&nbsp;Henriette de Loor,&nbsp;Pieter Evenepoel,&nbsp;Kelly S. Swanson,&nbsp;Matthew R. Allen,&nbsp;Sharon M. Moe","doi":"10.1002/jbm4.10837","DOIUrl":"10.1002/jbm4.10837","url":null,"abstract":"<p>Chronic kidney disease (CKD)–mineral bone disorder (CKD-MBD) leads to fractures and cardiovascular disease. Observational studies suggest beneficial effects of dietary fiber on both bone and cardiovascular outcomes, but the effect of fiber on CKD-MBD is unknown. To determine the effect of fiber on CKD-MBD, we fed the Cy/+ rat with progressive CKD a casein-based diet of 0.7% phosphate with 10% inulin (fermentable fiber) or cellulose (non-fermentable fiber) from 22 weeks to either 30 or 32 weeks of age (~30% and ~15% of normal kidney function; CKD 4 and 5). We assessed CKD-MBD end points of biochemistry, bone quantity and quality, cardiovascular health, and cecal microbiota and serum gut-derived uremic toxins. Results were analyzed by two-way analysis of variance (ANOVA) to evaluate the main effects of CKD stage and inulin, and their interaction. The results showed that in CKD animals, inulin did not alter kidney function but reduced the increase from stage 4 to 5 in serum levels of phosphate and parathyroid hormone, but not fibroblast growth factor-23 (FGF23). Bone turnover and cortical bone parameters were similarly improved but mechanical properties were not altered. Inulin slowed progression of aorta and cardiac calcification, left ventricular mass index, and fibrosis. To understand the mechanism, we assessed intestinal microbiota and found changes in alpha and beta diversity and significant changes in several taxa with inulin, together with a reduction in circulating gut derived uremic toxins such as indoxyl sulfate and short-chain fatty acids. In conclusion, the addition of the fermentable fiber inulin to the diet of CKD rats led to a slowed progression of CKD-MBD without affecting kidney function, likely mediated by changes in the gut microbiota composition and lowered gut-derived uremic toxins. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10837","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138591935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Osteoclast microRNA Profiling in Rheumatoid Arthritis to Capture the Erosive Factor 修正类风湿性关节炎破骨细胞 microRNA 图谱以捕捉侵蚀因子
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-12-01 DOI: 10.1002/jbm4.10845

Nguyen HD, Lortie A, Mbous Nguimbus L, et al. Osteoclast microRNA profiling in rheumatoid arthritis to capture the erosive factor. JBMR Plus. 2023;7:e10776. https://doi.org/10.1002/jbm4.10776

In the originally published version of the article, the author's names were inadvertently transposed. The correct author list appears below. The online version of this article has been corrected accordingly.

We apologize for this error.

Hoang Dong Nguyen,1 Audrey Lortie,2 Léopold Mbous Nguimbus,2 Javier Marrugo,2 Hugues Allard-Chamard,2 Luigi Bouchard,1,3 Gilles Boire,2 Michelle S Scott,1 and Sophie Roux 2.

1Department of Biochemistry and Functional Genomics, University of Sherbrooke and Research Centre of the Centre Intégré Universitaire de Santé et Services Sociaux de l'Estrie – Centre Hospitalier Universitaire de Sherbrooke (CIUSSSE-CHUS), Sherbrooke, Canada.

2Division of Rheumatology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke and Research Centre of the Centre Intégré Universitaire de Santé et Services Sociaux de l'Estrie – Centre Hospitalier Universitaire de Sherbrooke (CIUSSSE-CHUS), Sherbrooke, Canada.

3Department of Medical Biology, CIUSS du Saguenay-Lac-Saint-Jean Hôpital Universitaire de Chicoutimi, Saguenay, Canada.

Nguyen HD、Lortie A、Mbous Nguimbus L 等:类风湿性关节炎破骨细胞微RNA图谱分析捕捉侵蚀因子。JBMR Plus.2023;7:e10776。https://doi.org/10.1002/jbm4.10776In,在文章最初发表的版本中,作者姓名不慎调换。正确的作者名单如下。Hoang Dong Nguyen,1 Audrey Lortie,2 Léopold Mbous Nguimbus,2 Javier Marrugo,2 Hugues Allard-Chamard,2 Luigi Bouchard,1,3 Gilles Boire,2 Michelle S Scott,1 and Sophie Roux 2.1 加拿大舍布鲁克大学生物化学和功能基因组学系及埃斯特里大学保健和社会服务综合中心-舍布鲁克大学医院中心(CIUSSSE-CHUS)研究中心。加拿大舍布鲁克,舍布鲁克大学医学与健康科学学院医学系风湿病学部,以及爱斯特里省大学健康与社会服务综合中心--舍布鲁克大学医院中心(CIUSSSE-CHUS)研究中心.3 加拿大萨格奈-拉克-圣让大学医学生物学系,加拿大萨格奈,奇库蒂米大学医院.4 加拿大萨格奈-拉克-圣让大学医学生物学系,加拿大萨格奈,奇库蒂米大学医院.5 加拿大萨格奈-拉克-圣让大学医学生物学系,加拿大萨格奈,奇库蒂米大学医院.6 加拿大萨格奈-拉克-圣让大学医学生物学系,加拿大萨格奈,奇库蒂米大学医院.7 加拿大萨格奈-拉克-圣让大学医学生物学系,加拿大萨格奈,奇库蒂米大学医院.
{"title":"Correction to Osteoclast microRNA Profiling in Rheumatoid Arthritis to Capture the Erosive Factor","authors":"","doi":"10.1002/jbm4.10845","DOIUrl":"10.1002/jbm4.10845","url":null,"abstract":"<p>Nguyen HD, Lortie A, Mbous Nguimbus L, et al. Osteoclast microRNA profiling in rheumatoid arthritis to capture the erosive factor. <i>JBMR Plus</i>. 2023;7:e10776. https://doi.org/10.1002/jbm4.10776</p><p>In the originally published version of the article, the author's names were inadvertently transposed. The correct author list appears below. The online version of this article has been corrected accordingly.</p><p>We apologize for this error.</p><p>Hoang Dong Nguyen,<sup>1</sup> Audrey Lortie,<sup>2</sup> Léopold Mbous Nguimbus,<sup>2</sup> Javier Marrugo,<sup>2</sup> Hugues Allard-Chamard,<sup>2</sup> Luigi Bouchard,<sup>1</sup>,<sup>3</sup> Gilles Boire,<sup>2</sup> Michelle S Scott,<sup>1</sup> and Sophie Roux <sup>2</sup>.</p><p><sup>1</sup>Department of Biochemistry and Functional Genomics, University of Sherbrooke and Research Centre of the Centre Intégré Universitaire de Santé et Services Sociaux de l'Estrie – Centre Hospitalier Universitaire de Sherbrooke (CIUSSSE-CHUS), Sherbrooke, Canada.</p><p><sup>2</sup>Division of Rheumatology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Sherbrooke and Research Centre of the Centre Intégré Universitaire de Santé et Services Sociaux de l'Estrie – Centre Hospitalier Universitaire de Sherbrooke (CIUSSSE-CHUS), Sherbrooke, Canada.</p><p><sup>3</sup>Department of Medical Biology, CIUSS du Saguenay-Lac-Saint-Jean Hôpital Universitaire de Chicoutimi, Saguenay, Canada.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10845","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138617175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When Cortical Bone Matrix Properties Are Indiscernible between Elderly Men with and without Type 2 Diabetes, Fracture Resistance Follows Suit 当患有和未患有 2 型糖尿病的老年男性之间的骨皮质基质特性无法区分时,骨折抵抗力也会随之发生变化
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-12-01 DOI: 10.1002/jbm4.10839
Eva M. Wölfel, Benjamin Bartsch, Jasmin Koldehoff, Imke A. K. Fiedler, Sofie Dragoun-Kolibova, Felix N. Schmidt, Johannes Krug, Mei-Chun Lin, Klaus Püschel, Benjamin Ondruschka, Elizabeth A. Zimmermann, Hans Jelitto, Gerold Schneider, Bernd Gludovatz, Björn Busse

Type 2 diabetes mellitus (T2DM) is a metabolic disease affecting bone tissue and leading to increased fracture risk in men and women, independent of bone mineral density (BMD). Thus, bone material quality (i.e., properties that contribute to bone toughness but are not attributed to bone mass or quantity) is suggested to contribute to higher fracture risk in diabetic patients and has been shown to be altered. Fracture toughness properties are assumed to decline with aging and age-related disease, while toughness of human T2DM bone is mostly determined from compression testing of trabecular bone. In this case-control study, we determined fracture resistance in T2DM cortical bone tissue from male individuals in combination with a multiscale approach to assess bone material quality indices. All cortical bone samples stem from male nonosteoporotic individuals and show no significant differences in microstructure in both groups, control and T2DM. Bone material quality analyses reveal that both control and T2DM groups exhibit no significant differences in bone matrix composition assessed with Raman spectroscopy, in BMD distribution determined with quantitative back-scattered electron imaging, and in nanoscale local biomechanical properties assessed via nanoindentation. Finally, notched three-point bending tests revealed that the fracture resistance (measured from the total, elastic, and plastic J-integral) does not significantly differ in T2DM and control group, when both groups exhibit no significant differences in bone microstructure and material quality. This supports recent studies suggesting that not all T2DM patients are affected by a higher fracture risk but that individual risk profiles contribute to fracture susceptibility, which should spur further research on improving bone material quality assessment in vivo and identifying risk factors that increase bone fragility in T2DM. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

2型糖尿病(T2DM)是一种影响骨组织并导致男性和女性骨折风险增加的代谢性疾病,与骨矿物质密度(BMD)无关。因此,骨材料质量(即有助于骨韧性但不归因于骨量或数量的特性)被认为是糖尿病患者骨折风险较高的因素,并且已被证明是可以改变的。断裂韧性特性被认为随着年龄和年龄相关疾病而下降,而人类T2DM骨的韧性主要通过小梁骨的压缩试验来确定。在这项病例对照研究中,我们测定了男性T2DM皮质骨组织的骨折抵抗性,并结合多尺度方法评估骨材料质量指标。所有皮质骨样本均来自男性非骨质疏松症患者,两组、对照组和T2DM患者的微结构无显著差异。骨材料质量分析显示,对照组和T2DM组在拉曼光谱评估的骨基质组成、定量背散射电子成像确定的骨密度分布以及纳米压痕评估的纳米尺度局部生物力学性能方面均无显著差异。最后,缺口三点弯曲试验显示,当两组在骨微观结构和材料质量上没有显着差异时,T2DM组和对照组的断裂抗力(从总、弹性和塑性J积分测量)没有显着差异。这支持了最近的研究表明,并非所有T2DM患者都有较高的骨折风险,但个体风险概况有助于骨折易感性,这应该促进进一步研究,以改善体内骨材料质量评估,并确定增加T2DM患者骨易碎性的危险因素。©2023作者。JBMR Plus由Wiley期刊有限责任公司代表美国骨骼和矿物研究协会出版。
{"title":"When Cortical Bone Matrix Properties Are Indiscernible between Elderly Men with and without Type 2 Diabetes, Fracture Resistance Follows Suit","authors":"Eva M. Wölfel,&nbsp;Benjamin Bartsch,&nbsp;Jasmin Koldehoff,&nbsp;Imke A. K. Fiedler,&nbsp;Sofie Dragoun-Kolibova,&nbsp;Felix N. Schmidt,&nbsp;Johannes Krug,&nbsp;Mei-Chun Lin,&nbsp;Klaus Püschel,&nbsp;Benjamin Ondruschka,&nbsp;Elizabeth A. Zimmermann,&nbsp;Hans Jelitto,&nbsp;Gerold Schneider,&nbsp;Bernd Gludovatz,&nbsp;Björn Busse","doi":"10.1002/jbm4.10839","DOIUrl":"10.1002/jbm4.10839","url":null,"abstract":"<p>Type 2 diabetes mellitus (T2DM) is a metabolic disease affecting bone tissue and leading to increased fracture risk in men and women, independent of bone mineral density (BMD). Thus, bone material quality (i.e., properties that contribute to bone toughness but are not attributed to bone mass or quantity) is suggested to contribute to higher fracture risk in diabetic patients and has been shown to be altered. Fracture toughness properties are assumed to decline with aging and age-related disease, while toughness of human T2DM bone is mostly determined from compression testing of trabecular bone. In this case-control study, we determined fracture resistance in T2DM cortical bone tissue from male individuals in combination with a multiscale approach to assess bone material quality indices. All cortical bone samples stem from male nonosteoporotic individuals and show no significant differences in microstructure in both groups, control and T2DM. Bone material quality analyses reveal that both control and T2DM groups exhibit no significant differences in bone matrix composition assessed with Raman spectroscopy, in BMD distribution determined with quantitative back-scattered electron imaging, and in nanoscale local biomechanical properties assessed via nanoindentation. Finally, notched three-point bending tests revealed that the fracture resistance (measured from the total, elastic, and plastic J-integral) does not significantly differ in T2DM and control group, when both groups exhibit no significant differences in bone microstructure and material quality. This supports recent studies suggesting that not all T2DM patients are affected by a higher fracture risk but that individual risk profiles contribute to fracture susceptibility, which should spur further research on improving bone material quality assessment in vivo and identifying risk factors that increase bone fragility in T2DM. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10839","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138625747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Asfotase Alfa on Plasma and Urine Pyrophosphate Levels and Pseudofractures in a Patient With Adult-Onset Hypophosphatasia 阿斯福太酶α对一名成人型低磷血症患者血浆和尿液焦磷酸盐水平以及假性骨折的影响
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-20 DOI: 10.1002/jbm4.10842
Naoko Hidaka, Hiroaki Murata, Kanako Tachikawa, Keiichi Osaki, Takashi Sekiyama, Yuka Kinoshita, Hajime Kato, Yoshitomo Hoshino, Soichiro Kimura, Takashi Sunouchi, So Watanabe, Masaomi Nangaku, Noriko Makita, Toshimi Michigami, Nobuaki Ito

Hypophosphatasia (HPP) is an inherited disease caused by variants of the ALPL gene encoding tissue-nonspecific alkaline phosphatase. Adult-onset HPP (adult HPP), known as a mild form of HPP, develops symptoms involving osteomalacia after the age of 18 years. Asfotase alfa (AA) is a modulated recombinant human alkaline phosphatase (ALP) that has been established as a first-line therapy for severe forms of HPP, such as perinatal and infantile forms. We described a 64-year-old female who presented with pseudofractures in bilateral femur diaphyses and impaired mobility. Low serum ALP activity and a high concentration of urine phosphoethanolamine indicated the diagnosis of HPP, which was confirmed by the identification of a homozygous variant in the ALPL gene (c.319G > A; p.Val107Ile). An in vitro transfection experiment to measure the ALP activity of this novel variant protein was performed, resulting in 40% of the residual enzymatic activity compared with the wild type. AA was initiated to facilitate the union of pseudofracture and to improve mobility. After 6 months, radiographic images revealed the disappearance of fracture lines, and improvement of ambulatory ability was confirmed by the 6-minute walk test (525 to 606 m). The EQ-5D-5L index was also improved (0.757 to 0.895). Within a follow-up period, the levels of urine pyrophosphate corrected by urine creatinine (uPPi/Cre) declined in parallel with the level of plasma PPi (plasma PPi: 6.34 to 1.04 μM, uPPi/Cre: 226.8 to 75.4 nmol/mg). The beneficial effect of AA on pseudofracture healing in adult HPP was presented, although the application of AA should be restricted to patients exhibiting relatively severe manifestations. In addition, a novel pathogenic variant of the ALPL gene was identified with the supportive result of functional analysis. Furthermore, when monitoring patients with HPP treated with AA, uPPi/Cre might be a convenient substitute for plasma PPi, which requires immediate filtration after blood sampling. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.

低磷酸盐血症(HPP)是一种遗传性疾病,由编码组织非特异性碱性磷酸酶的 ALPL 基因变异引起。成人发病型 HPP(成人 HPP)是一种轻型 HPP,在 18 岁以后出现骨软化症状。阿斯福太酶α(AA)是一种调节型重组人碱性磷酸酶(ALP),已被确定为围产期和婴儿期等严重型 HPP 的一线疗法。我们描述了一名 64 岁女性的病例,她出现双侧股骨骨骺假性骨折,行动不便。低血清 ALP 活性和高浓度尿磷乙醇胺表明她被诊断为 HPP,而 ALPL 基因的同源变异(c.319G > A; p.Val107Ile)也证实了这一诊断。通过体外转染实验测量了这种新型变异蛋白的 ALP 活性,结果发现与野生型相比,该变异蛋白的剩余酶活性降低了 40%。为了促进假骨折的结合并改善活动度,患者开始接受 AA 治疗。6 个月后,放射影像显示骨折线消失,6 分钟步行测试(525 米至 606 米)证实患者的活动能力得到改善。EQ-5D-5L 指数也有所改善(从 0.757 升至 0.895)。在随访期间,尿肌酐校正尿焦磷酸水平(uPPi/Cre)与血浆 PPi 水平同步下降(血浆 PPi:6.34 降至 1.04 μM,uPPi/Cre:226.8 降至 75.4 nmol/mg)。尽管 AA 的应用应仅限于表现相对严重的患者,但它对成人 HPP 假性骨折愈合的有利影响还是显现出来了。此外,研究还发现了 ALPL 基因的一种新型致病变体,并通过功能分析得出了支持性结果。此外,在监测接受 AA 治疗的 HPP 患者时,uPPi/Cre 可能是血浆 PPi 的方便替代品,因为血浆 PPi 需要在采血后立即过滤。© 2023 作者。JBMR Plus 由 Wiley Periodicals LLC.代表美国骨矿研究学会出版。
{"title":"The Effect of Asfotase Alfa on Plasma and Urine Pyrophosphate Levels and Pseudofractures in a Patient With Adult-Onset Hypophosphatasia","authors":"Naoko Hidaka,&nbsp;Hiroaki Murata,&nbsp;Kanako Tachikawa,&nbsp;Keiichi Osaki,&nbsp;Takashi Sekiyama,&nbsp;Yuka Kinoshita,&nbsp;Hajime Kato,&nbsp;Yoshitomo Hoshino,&nbsp;Soichiro Kimura,&nbsp;Takashi Sunouchi,&nbsp;So Watanabe,&nbsp;Masaomi Nangaku,&nbsp;Noriko Makita,&nbsp;Toshimi Michigami,&nbsp;Nobuaki Ito","doi":"10.1002/jbm4.10842","DOIUrl":"10.1002/jbm4.10842","url":null,"abstract":"<p>Hypophosphatasia (HPP) is an inherited disease caused by variants of the <i>ALPL</i> gene encoding tissue-nonspecific alkaline phosphatase. Adult-onset HPP (adult HPP), known as a mild form of HPP, develops symptoms involving osteomalacia after the age of 18 years. Asfotase alfa (AA) is a modulated recombinant human alkaline phosphatase (ALP) that has been established as a first-line therapy for severe forms of HPP, such as perinatal and infantile forms. We described a 64-year-old female who presented with pseudofractures in bilateral femur diaphyses and impaired mobility. Low serum ALP activity and a high concentration of urine phosphoethanolamine indicated the diagnosis of HPP, which was confirmed by the identification of a homozygous variant in the <i>ALPL</i> gene (c.319G &gt; A; p.Val107Ile). An in vitro transfection experiment to measure the ALP activity of this novel variant protein was performed, resulting in 40% of the residual enzymatic activity compared with the wild type. AA was initiated to facilitate the union of pseudofracture and to improve mobility. After 6 months, radiographic images revealed the disappearance of fracture lines, and improvement of ambulatory ability was confirmed by the 6-minute walk test (525 to 606 m). The EQ-5D-5L index was also improved (0.757 to 0.895). Within a follow-up period, the levels of urine pyrophosphate corrected by urine creatinine (uPPi/Cre) declined in parallel with the level of plasma PPi (plasma PPi: 6.34 to 1.04 μM, uPPi/Cre: 226.8 to 75.4 nmol/mg). The beneficial effect of AA on pseudofracture healing in adult HPP was presented, although the application of AA should be restricted to patients exhibiting relatively severe manifestations. In addition, a novel pathogenic variant of the <i>ALPL</i> gene was identified with the supportive result of functional analysis. Furthermore, when monitoring patients with HPP treated with AA, uPPi/Cre might be a convenient substitute for plasma PPi, which requires immediate filtration after blood sampling. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10842","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138822505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utility and Limitations of TALLYHO/JngJ as a Model for Type 2 Diabetes–Induced Bone Disease TALLYHO/JngJ 作为 2 型糖尿病诱发骨病模型的实用性和局限性
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-17 DOI: 10.1002/jbm4.10843
Lejla Emini, Juliane Salbach-Hirsch, Johannes Krug, Katharina Jähn-Rickert, Björn Busse, Martina Rauner, Lorenz C. Hofbauer

Type 2 diabetes mellitus (T2DM) increases risk of fractures due to bone microstructural and material deficits, though the mechanisms remain unclear. Preclinical models mimicking diabetic bone disease are required to further understand its pathogenesis. The TALLYHO/JngJ (TH) mouse is a polygenic model recapitulating adolescent-onset T2DM in humans. Due to incomplete penetrance of the phenotype ~25% of male TH mice never develop hyperglycemia, providing a strain-matched nondiabetic control. We performed a comprehensive characterization of the metabolic and skeletal phenotype of diabetic TH mice and compared them to either their nondiabetic TH controls or the recommended SWR/J controls to evaluate their suitability to study diabetic bone disease in humans. Compared to both controls, male TH mice with T2DM exhibited higher blood glucose levels, weight along with impaired glucose tolerance and insulin sensitivity. TH mice with/without T2DM displayed higher cortical bone parameters and lower trabecular bone parameters in the femurs and vertebrae compared to SWR/J. The mechanical properties remained unchanged for all three groups except for a low-energy failure in TH mice with T2DM only compared to SWR/J. Histomorphometry analyses only revealed higher number of osteoclasts and osteocytes for SWR/J compared to both groups of TH. Bone turnover markers procollagen type 1 N-terminal propeptide (P1NP) and tartrate-resistant acid phosphatase (TRAP) were low for both groups of TH mice compared to SWR/J. Silver nitrate staining of the femurs revealed low number of osteocyte lacunar and dendrites in TH mice with T2DM. Three-dimensional assessment showed reduced lacunar parameters in trabecular and cortical bone. Notably, osteocyte morphology changed in TH mice with T2DM compared to SWR/J. In summary, our study highlights the utility of the TH mouse to study T2DM, but not necessarily T2DM-induced bone disease, as there were no differences in bone strength and bone cell parameters between diabetic and non-diabetic TH mice. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

2 型糖尿病(T2DM)会因骨骼微结构和材料缺陷而增加骨折风险,但其机制仍不清楚。为进一步了解糖尿病骨病的发病机制,需要建立模拟糖尿病骨病的临床前模型。TALLYHO/JngJ(TH)小鼠是一种重现人类青春期发病的 T2DM 的多基因模型。由于表型的不完全渗透性,约有 25% 的雄性 TH 小鼠从未发生过高血糖,从而提供了一个品系匹配的非糖尿病对照。我们对糖尿病 TH 小鼠的代谢和骨骼表型进行了全面鉴定,并将其与非糖尿病 TH 对照组或推荐的 SWR/J 对照组进行了比较,以评估它们是否适合研究人类糖尿病骨病。与两个对照组相比,患有 T2DM 的雄性 TH 小鼠表现出较高的血糖水平、体重以及葡萄糖耐量和胰岛素敏感性受损。与 SWR/J 小鼠相比,患有/不患有 T2DM 的 TH 小鼠的股骨和椎骨的皮质骨参数较高,而骨小梁参数较低;与 SWR/J 小鼠相比,除了患有 T2DM 的 TH 小鼠出现低能衰竭外,其他三组小鼠的机械性能均保持不变。与SWR/J相比,两组TH小鼠的骨转换标志物1型胶原蛋白N端前肽(P1NP)和耐酒石酸磷酸酶(TRAP)都较低。硝酸银染色显示,患有T2DM的TH小鼠股骨中的骨细胞裂隙和树突数量较少。三维评估显示,骨小梁和皮质骨的裂隙参数降低。总之,我们的研究强调了TH小鼠在研究T2DM的实用性,但不一定是T2DM诱导的骨病,因为糖尿病和非糖尿病TH小鼠的骨强度和骨细胞参数没有差异。© 2023 作者。JBMR Plus 由 Wiley Periodicals LLC 代表美国骨与矿物质研究学会出版。
{"title":"Utility and Limitations of TALLYHO/JngJ as a Model for Type 2 Diabetes–Induced Bone Disease","authors":"Lejla Emini,&nbsp;Juliane Salbach-Hirsch,&nbsp;Johannes Krug,&nbsp;Katharina Jähn-Rickert,&nbsp;Björn Busse,&nbsp;Martina Rauner,&nbsp;Lorenz C. Hofbauer","doi":"10.1002/jbm4.10843","DOIUrl":"10.1002/jbm4.10843","url":null,"abstract":"<p>Type 2 diabetes mellitus (T2DM) increases risk of fractures due to bone microstructural and material deficits, though the mechanisms remain unclear. Preclinical models mimicking diabetic bone disease are required to further understand its pathogenesis. The TALLYHO/JngJ (TH) mouse is a polygenic model recapitulating adolescent-onset T2DM in humans. Due to incomplete penetrance of the phenotype ~25% of male TH mice never develop hyperglycemia, providing a strain-matched nondiabetic control. We performed a comprehensive characterization of the metabolic and skeletal phenotype of diabetic TH mice and compared them to either their nondiabetic TH controls or the recommended SWR/J controls to evaluate their suitability to study diabetic bone disease in humans. Compared to both controls, male TH mice with T2DM exhibited higher blood glucose levels, weight along with impaired glucose tolerance and insulin sensitivity. TH mice with/without T2DM displayed higher cortical bone parameters and lower trabecular bone parameters in the femurs and vertebrae compared to SWR/J. The mechanical properties remained unchanged for all three groups except for a low-energy failure in TH mice with T2DM only compared to SWR/J. Histomorphometry analyses only revealed higher number of osteoclasts and osteocytes for SWR/J compared to both groups of TH. Bone turnover markers procollagen type 1 N-terminal propeptide (P1NP) and tartrate-resistant acid phosphatase (TRAP) were low for both groups of TH mice compared to SWR/J. Silver nitrate staining of the femurs revealed low number of osteocyte lacunar and dendrites in TH mice with T2DM. Three-dimensional assessment showed reduced lacunar parameters in trabecular and cortical bone. Notably, osteocyte morphology changed in TH mice with T2DM compared to SWR/J. In summary, our study highlights the utility of the TH mouse to study T2DM, but not necessarily T2DM-induced bone disease, as there were no differences in bone strength and bone cell parameters between diabetic and non-diabetic TH mice. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10843","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138822438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1–84) 接受 rhPTH(1-84) 治疗的甲状旁腺功能减退症患者骨皮质内骨重塑过程中的短暂活化和从侵蚀到形成的过渡得到改善
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-17 DOI: 10.1002/jbm4.10829
Pernille van Dijk Christiansen, Tanja Sikjær, Christina Møller Andreasen, Jesper Skovhus Thomsen, Annemarie Brüel, Ellen Margrethe Hauge, Jean-Marie Delaisse, Lars Rejnmark, Thomas Levin Andersen

In hypoparathyroidism, lack of parathyroid hormone (PTH) leads to low calcium levels and decreased bone remodeling. Treatment with recombinant human PTH (rhPTH) may normalize bone turnover. This study aimed to investigate whether rhPTH(1–84) continued to activate intracortical bone remodeling after 30 months and promoted the transition from erosion to formation and whether this effect was transitory when rhPTH(1–84) was discontinued. Cortical histomorphometry was performed on 60 bone biopsies from patients (aged 31 to 78 years) with chronic hypoparathyroidism randomized to either 100 μg rhPTH(1–84) a day (n = 21) (PTH) or similar placebo (n = 21) (PLB) for 6 months as add-on to conventional therapy. This was followed by an open-label extension, where patients extended their rhPTH(1–84) (PTH) (n = 5), continued conventional treatment (CON) (n = 5), or withdrew from rhPTH(1–84) and resumed conventional therapy (PTHw) for an additional 24 months (n = 8). Bone biopsies were collected at months 6 (n = 42) and 30 (n = 18). After 6 and 30 months, the overall cortical microarchitecture (cortical porosity, thickness, pore density, and mean pore diameter) in the PTH group did not differ from that of the PLB/CON and PTHw groups. Still, the PTH group had a significantly and persistently higher percentage of pores undergoing remodeling than the PLB/CON groups. A significantly higher percentage of these pores was undergoing bone formation in the PTH compared with the PLB/CON groups, whereas the percentage of pores with erosion only was not different. This resulted in a shift in the ratio between formative and eroded pores, reflecting a faster transition from erosion to formation in the PTH-treated patients. In the rhPTH(1–84) withdrawal group PTHw, the latter effects of PTH were completely reversed in comparison to those of the PLB/CON groups. In conclusion, rhPTH(1–84) replacement therapy in hypoparathyroidism patients promotes intracortical remodeling and its transition from erosion to formation without affecting the overall cortical microstructure. The effect persists for at least 30 months and is reversible when treatment is withdrawn. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

在甲状旁腺功能减退症患者中,甲状旁腺激素(PTH)的缺乏会导致低血钙水平和骨重塑减少。使用重组人PTH(rhPTH)治疗可使骨转换恢复正常。本研究旨在探讨rhPTH(1-84)是否在30个月后继续激活皮质内骨重塑并促进从侵蚀到形成的转变,以及当rhPTH(1-84)停用时这种作用是否会短暂消失。研究人员对60例慢性甲状旁腺功能减退症患者(年龄在31至78岁之间)的骨活检组织进行了皮质组织形态测量,这些患者被随机分配到每天100微克的rhPTH(1-84)(n = 21)(PTH)或类似的安慰剂(n = 21)(PLB)中,为期6个月,作为常规治疗的补充。随后是开放标签延长期,患者延长rhPTH(1-84) (PTH)(5例),继续常规治疗(CON)(5例),或停用rhPTH(1-84),恢复常规治疗(PTHw),延长24个月(8例)。在第 6 个月(n = 42)和第 30 个月(n = 18)收集骨活检。6 个月和 30 个月后,PTH 组的整体皮质微结构(皮质孔隙率、厚度、孔密度和平均孔直径)与 PLB/CON 组和 PTHw 组没有差异。不过,PTH 组发生重塑的孔隙比例明显且持续高于 PLB/CON 组。与 PLB/CON 组相比,PTH 组正在进行骨形成的孔隙比例明显更高,而仅发生侵蚀的孔隙比例则没有差异。这导致形成孔和侵蚀孔之间的比例发生了变化,反映出 PTH 治疗组患者从侵蚀到形成的转变速度更快。在停用 rhPTH(1-84) 的 PTHw 组中,与 PLB/CON 组相比,PTH 的后一种效应被完全逆转。总之,甲状旁腺功能减退症患者的rhPTH(1-84)替代疗法可促进皮质内重塑及其从侵蚀向形成的转变,而不会影响整体皮质微结构。这种效应可持续至少30个月,并且在停止治疗时是可逆的。© 2023 作者。JBMR Plus 由 Wiley Periodicals LLC 代表美国骨与矿物质研究学会出版。
{"title":"Transitory Activation and Improved Transition from Erosion to Formation within Intracortical Bone Remodeling in Hypoparathyroid Patients Treated with rhPTH(1–84)","authors":"Pernille van Dijk Christiansen,&nbsp;Tanja Sikjær,&nbsp;Christina Møller Andreasen,&nbsp;Jesper Skovhus Thomsen,&nbsp;Annemarie Brüel,&nbsp;Ellen Margrethe Hauge,&nbsp;Jean-Marie Delaisse,&nbsp;Lars Rejnmark,&nbsp;Thomas Levin Andersen","doi":"10.1002/jbm4.10829","DOIUrl":"10.1002/jbm4.10829","url":null,"abstract":"<p>In hypoparathyroidism, lack of parathyroid hormone (PTH) leads to low calcium levels and decreased bone remodeling. Treatment with recombinant human PTH (rhPTH) may normalize bone turnover. This study aimed to investigate whether rhPTH(1–84) continued to activate intracortical bone remodeling after 30 months and promoted the transition from erosion to formation and whether this effect was transitory when rhPTH(1–84) was discontinued. Cortical histomorphometry was performed on 60 bone biopsies from patients (aged 31 to 78 years) with chronic hypoparathyroidism randomized to either 100 μg rhPTH(1–84) a day (<i>n</i> = 21) (PTH) or similar placebo (<i>n</i> = 21) (PLB) for 6 months as add-on to conventional therapy. This was followed by an open-label extension, where patients extended their rhPTH(1–84) (PTH) (<i>n</i> = 5), continued conventional treatment (CON) (<i>n</i> = 5), or withdrew from rhPTH(1–84) and resumed conventional therapy (PTHw) for an additional 24 months (<i>n</i> = 8). Bone biopsies were collected at months 6 (<i>n</i> = 42) and 30 (<i>n</i> = 18). After 6 and 30 months, the overall cortical microarchitecture (cortical porosity, thickness, pore density, and mean pore diameter) in the PTH group did not differ from that of the PLB/CON and PTHw groups. Still, the PTH group had a significantly and persistently higher percentage of pores undergoing remodeling than the PLB/CON groups. A significantly higher percentage of these pores was undergoing bone formation in the PTH compared with the PLB/CON groups, whereas the percentage of pores with erosion only was not different. This resulted in a shift in the ratio between formative and eroded pores, reflecting a faster transition from erosion to formation in the PTH-treated patients. In the rhPTH(1–84) withdrawal group PTHw, the latter effects of PTH were completely reversed in comparison to those of the PLB/CON groups. In conclusion, rhPTH(1–84) replacement therapy in hypoparathyroidism patients promotes intracortical remodeling and its transition from erosion to formation without affecting the overall cortical microstructure. The effect persists for at least 30 months and is reversible when treatment is withdrawn. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10829","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138822437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased Osteoblast GαS Promotes Ossification by Suppressing Cartilage and Enhancing Callus Mineralization During Fracture Repair in Mice 在小鼠骨折修复过程中,成骨细胞 GαS 的增加通过抑制软骨和增强胼胝体矿化促进骨化
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-15 DOI: 10.1002/jbm4.10841
Kathy K Lee, Adele Changoor, Marc D Grynpas, Jane Mitchell

S, the stimulatory G protein α-subunit that raises intracellular cAMP levels by activating adenylyl cyclase, plays a vital role in bone development, maintenance, and remodeling. Previously, using transgenic mice overexpressing GαS in osteoblasts (GS-Tg), we demonstrated the influence of osteoblast GαS level on osteogenesis, bone turnover, and skeletal responses to hyperparathyroidism. To further investigate whether alterations in GαS levels affect endochondral bone repair, a postnatal bone regenerative process that recapitulates embryonic bone development, we performed stabilized tibial osteotomy in male GS-Tg mice at 8 weeks of age and examined the progression of fracture healing by micro-CT, histomorphometry, and gene expression analysis over a 4-week period. Bone fractures from GS-Tg mice exhibited diminished cartilage formation at the time of peak soft callus formation at 1 week post-fracture followed by significantly enhanced callus mineralization and new bone formation at 2 weeks post-fracture. The opposing effects on chondrogenesis and osteogenesis were validated by downregulation of chondrogenic markers and upregulation of osteogenic markers. Histomorphometric analysis at times of increased bone formation (2 and 3 weeks post-fracture) revealed excess fibroblast-like cells on newly formed woven bone surfaces and elevated osteocyte density in GS-Tg fractures. Coincident with enhanced callus mineralization and bone formation, GS-Tg mice showed elevated active β-catenin and Wntless proteins in osteoblasts at 2 weeks post-fracture, further substantiated by increased mRNA encoding various canonical Wnts and Wnt target genes, suggesting elevated osteoblastic Wnt secretion and Wnt/β-catenin signaling. The GS-Tg bony callus at 4 weeks post-fracture exhibited greater mineral density and decreased polar moment of inertia, resulting in improved material stiffness. These findings highlight that elevated GαS levels increase Wnt signaling, conferring an increased osteogenic differentiation potential at the expense of chondrogenic differentiation, resulting in improved mechanical integrity. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.

GαS是刺激性G蛋白α亚基,通过激活腺苷酸环化酶提高细胞内cAMP水平,在骨骼发育、维持和重塑过程中发挥着重要作用。此前,我们利用在成骨细胞中过表达 GαS 的转基因小鼠(GS-Tg)证明了成骨细胞 GαS 水平对骨生成、骨转换和骨骼对甲状旁腺功能亢进反应的影响。为了进一步研究GαS水平的改变是否会影响软骨内骨修复(一种重现胚胎骨发育的产后骨再生过程),我们在雄性GS-Tg小鼠8周龄时对其进行了稳定的胫骨截骨术,并在4周时间内通过显微CT、组织形态学和基因表达分析检查了骨折愈合的进展。GS-Tg小鼠的骨折在骨折后1周达到软茧形成高峰时软骨形成减少,随后在骨折后2周胼胝矿化和新骨形成明显增强。软骨生成标志物的下调和成骨标志物的上调验证了对软骨生成和成骨的相反影响。在骨形成增加时(骨折后2周和3周)进行的组织形态学分析显示,GS-Tg骨折患者新形成的编织骨表面有过量的成纤维细胞,骨细胞密度升高。在胼胝体矿化和骨形成增强的同时,GS-Tg 小鼠在骨折后 2 周显示成骨细胞中活性 β-catenin 和 Wntless 蛋白升高,编码各种典型 Wnts 和 Wnt 靶基因的 mRNA 增加进一步证实了这一点,表明成骨细胞 Wnt 分泌和 Wnt/β-catenin 信号传导增强。骨折后4周的GS-Tg骨性胼胝体显示出更高的矿物质密度和更低的极性惯性矩,从而改善了材料的硬度。这些发现突出表明,GαS水平升高会增加Wnt信号传导,从而提高成骨分化潜能,牺牲软骨分化,从而改善机械完整性。© 2023 作者。JBMR Plus 由 Wiley Periodicals LLC.代表美国骨与矿物质研究学会出版。
{"title":"Increased Osteoblast GαS Promotes Ossification by Suppressing Cartilage and Enhancing Callus Mineralization During Fracture Repair in Mice","authors":"Kathy K Lee,&nbsp;Adele Changoor,&nbsp;Marc D Grynpas,&nbsp;Jane Mitchell","doi":"10.1002/jbm4.10841","DOIUrl":"10.1002/jbm4.10841","url":null,"abstract":"<p>Gα<sub>S</sub>, the stimulatory G protein α-subunit that raises intracellular cAMP levels by activating adenylyl cyclase, plays a vital role in bone development, maintenance, and remodeling. Previously, using transgenic mice overexpressing Gα<sub>S</sub> in osteoblasts (G<sub>S</sub>-Tg), we demonstrated the influence of osteoblast Gα<sub>S</sub> level on osteogenesis, bone turnover, and skeletal responses to hyperparathyroidism. To further investigate whether alterations in Gα<sub>S</sub> levels affect endochondral bone repair, a postnatal bone regenerative process that recapitulates embryonic bone development, we performed stabilized tibial osteotomy in male G<sub>S</sub>-Tg mice at 8 weeks of age and examined the progression of fracture healing by micro-CT, histomorphometry, and gene expression analysis over a 4-week period. Bone fractures from G<sub>S</sub>-Tg mice exhibited diminished cartilage formation at the time of peak soft callus formation at 1 week post-fracture followed by significantly enhanced callus mineralization and new bone formation at 2 weeks post-fracture. The opposing effects on chondrogenesis and osteogenesis were validated by downregulation of chondrogenic markers and upregulation of osteogenic markers. Histomorphometric analysis at times of increased bone formation (2 and 3 weeks post-fracture) revealed excess fibroblast-like cells on newly formed woven bone surfaces and elevated osteocyte density in G<sub>S</sub>-Tg fractures. Coincident with enhanced callus mineralization and bone formation, G<sub>S</sub>-Tg mice showed elevated active β-catenin and Wntless proteins in osteoblasts at 2 weeks post-fracture, further substantiated by increased mRNA encoding various canonical Wnts and Wnt target genes, suggesting elevated osteoblastic Wnt secretion and Wnt/β-catenin signaling. The G<sub>S</sub>-Tg bony callus at 4 weeks post-fracture exhibited greater mineral density and decreased polar moment of inertia, resulting in improved material stiffness. These findings highlight that elevated Gα<sub>S</sub> levels increase Wnt signaling, conferring an increased osteogenic differentiation potential at the expense of chondrogenic differentiation, resulting in improved mechanical integrity. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10841","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138822395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fruit and Vegetable Consumption and the Risk of Bone Fracture: A Grading of Recommendations, Assessment, Development, and Evaluations (GRADE)-Assessed Systematic Review and Dose–Response Meta-Analysis 水果和蔬菜摄入量与骨折风险:建议、评估、发展和评价分级(GRADE)评估的系统性综述和剂量反应元分析
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-10 DOI: 10.1002/jbm4.10840
Sheida Zeraattalab-Motlagh, Seyed Mojtaba Ghoreishy, Arman Arab, Sara Mahmoodi, Amirhossein Hemmati, Hamed Mohammadi

Researchers have examined the link between consuming fruit and vegetables and the incidence of fractures for many years. Nevertheless, their findings have been unclear. Furthermore, the dose-dependent relationship has not been examined, and the level of certainty in the evidence was not evaluated. We carried out a dose-dependent meta-analysis examining the relation between fruit and vegetables intake and fracture incidence. PubMed, Web of Sciences, and Scopus were searched until April 2023 for cohort studies evaluating the relation between fruit and vegetables and fracture incidence. Summary relative risks (RRs) were computed from complied data by applying random effects analysis. To examine the level of evidence, we utilized the approach called the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE). Ten cohort studies comprising 511,716 individuals were entered. There was a nonsignificant relation between fruit and vegetables, as well as only fruit intake and any fracture risk. In contrast, high versus low analysis presented that vegetables consumption was linked to a 16% decrease in any type of fracture incidence (RR 0.84; 95% confidence interval [CI], 0.75 to 0.95; I2 = 83.1%; n = 6). Also, per one serving/day (200 g/day) increments in vegetables consumption, there was a 14% decline in the fracture risk (RR 0.86; 95% CI, 0.77 to 0.97; I2 = 84.7%; n = 5; GRADE = moderate). With moderate certainty, a greater consumption of only vegetables, but not total fruit and vegetables or only fruit, might reduce the risk of fracture. These associations were also evident in dose–response analysis. Large intervention trials are demanded to approve our findings. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

多年来,研究人员一直在研究食用水果和蔬菜与骨折发生率之间的联系。然而,他们的研究结果并不明确。此外,还没有研究过剂量依赖关系,也没有评估过证据的确定性水平。我们进行了一项剂量依赖性荟萃分析,研究水果和蔬菜摄入量与骨折发生率之间的关系。截至 2023 年 4 月,我们在 PubMed、Web of Sciences 和 Scopus 上检索了评估水果和蔬菜与骨折发生率之间关系的队列研究。通过应用随机效应分析法,从汇总的数据中计算出汇总相对风险(RRs)。为了考察证据的水平,我们采用了名为 "建议、评估、发展和评价分级"(GRADE)的方法。十项队列研究共涉及 511 716 人。水果和蔬菜之间以及仅水果摄入量与任何骨折风险之间的关系均不显著。相比之下,高与低的分析表明,蔬菜摄入量与任何类型骨折发病率下降 16% 有关(RR 0.84;95% 置信区间 [CI],0.75 至 0.95;I2 = 83.1%;n = 6)。此外,蔬菜消费量每增加一份/天(200 克/天),骨折风险就会下降 14%(RR 0.86;95% CI,0.77 至 0.97;I2 = 84.7%;n = 5;GRADE = 中等)。在中度确定性的情况下,多吃蔬菜,而不是多吃水果和蔬菜或只吃水果,可能会降低骨折风险。这些关联在剂量反应分析中也很明显。我们需要大型干预试验来验证我们的研究结果。© 2023 作者。JBMR Plus 由 Wiley Periodicals LLC 代表美国骨与矿物质研究学会出版。
{"title":"Fruit and Vegetable Consumption and the Risk of Bone Fracture: A Grading of Recommendations, Assessment, Development, and Evaluations (GRADE)-Assessed Systematic Review and Dose–Response Meta-Analysis","authors":"Sheida Zeraattalab-Motlagh,&nbsp;Seyed Mojtaba Ghoreishy,&nbsp;Arman Arab,&nbsp;Sara Mahmoodi,&nbsp;Amirhossein Hemmati,&nbsp;Hamed Mohammadi","doi":"10.1002/jbm4.10840","DOIUrl":"10.1002/jbm4.10840","url":null,"abstract":"<p>Researchers have examined the link between consuming fruit and vegetables and the incidence of fractures for many years. Nevertheless, their findings have been unclear. Furthermore, the dose-dependent relationship has not been examined, and the level of certainty in the evidence was not evaluated. We carried out a dose-dependent meta-analysis examining the relation between fruit and vegetables intake and fracture incidence. PubMed, Web of Sciences, and Scopus were searched until April 2023 for cohort studies evaluating the relation between fruit and vegetables and fracture incidence. Summary relative risks (RRs) were computed from complied data by applying random effects analysis. To examine the level of evidence, we utilized the approach called the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE). Ten cohort studies comprising 511,716 individuals were entered. There was a nonsignificant relation between fruit and vegetables, as well as only fruit intake and any fracture risk. In contrast, high versus low analysis presented that vegetables consumption was linked to a 16% decrease in any type of fracture incidence (RR 0.84; 95% confidence interval [CI], 0.75 to 0.95; <i>I</i><sup>2</sup> = 83.1%; <i>n</i> = 6). Also, per one serving/day (200 g/day) increments in vegetables consumption, there was a 14% decline in the fracture risk (RR 0.86; 95% CI, 0.77 to 0.97; <i>I</i><sup>2</sup> = 84.7%; <i>n</i> = 5; GRADE = moderate). With moderate certainty, a greater consumption of only vegetables, but not total fruit and vegetables or only fruit, might reduce the risk of fracture. These associations were also evident in dose–response analysis. Large intervention trials are demanded to approve our findings. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10840","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135138191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia 小儿骨骼发育不良的血清细胞因子表达趋势
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-09 DOI: 10.1002/jbm4.10816
David A. O'Connell, Ricki S. Carroll, Angela L. Duker, Andrea J. Schelhaas, Marjorie M. Postell, Paul T. Fawcett, Michael B. Bober

The skeletal dysplasias are a heterogeneous group of genetic conditions caused by abnormalities of growth, development, and maintenance of bone and cartilage. Little is known about the roles that cytokines play in the inflammatory and non-inflammatory pathophysiology of skeletal dysplasia. We sought to test our hypothesis that cytokines would be differentially expressed in children with skeletal dysplasia as compared to typically growing controls. Cytokine levels were analyzed using the Cytokine Human Magnetic 25-Plex Panel (Invitrogen, Waltham, MA, USA); 136 growing individuals with skeletal dysplasia and compared to a cohort of 275 healthy pediatric control subjects. We focused on the expression of 12 cytokines across nine dysplasia cohorts. The most common skeletal dysplasia diagnoses were: achondroplasia (58), osteogenesis imperfecta (19), type II collagenopathies (11), multiple epiphyseal dysplasia (MED: 9), diastrophic dysplasia (8), metatropic dysplasia (8), and microcephalic osteodysplastic primordial dwarfism type II (MOPDII: 8). Of the 108 specific observations made, 45 (41.7%) demonstrated statistically significant differences of expression between controls and individuals with skeletal dysplasia. Four of the 12 analyzed cytokines demonstrated elevated expression above control levels in all of the dysplasia cohorts (interleukin 12 [IL-12], IL-13, interferon γ-induced protein 10 kDa [IP-10], regulated on activation, normal T cell expressed and secreted [RANTES]) and two demonstrated expression below control levels across all dysplasia cohorts (monocyte chemoattractant protein 1 [MCP-1], macrophage inflammatory protein-1β [MIP-1β]). The highest levels of overexpression were seen in MOPDII, with expression levels of IP-10 being increased 3.8-fold (p < 0.0001). The lowest statistically significant levels of expressions were in type II collagenopathies, with expression levels of MCP-1 being expressed 0.43-fold lower (p < 0.005). With this data, we hope to lay the groundwork for future directions in dysplasia research that will enhance our understanding of these complex signaling pathways. Looking forward, validating these early trends in cytokine expression, and associating the observed variations with trends in the progression of dysplasia may offer new candidates for clinical biomarkers or even new therapeutics. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.

骨骼发育不良是一组由骨骼和软骨的生长、发育和维护异常引起的遗传性疾病。人们对细胞因子在骨骼发育不良的炎症性和非炎症性病理生理学中的作用知之甚少。我们试图验证我们的假设,即与生长发育正常的对照组相比,骨骼发育不良儿童体内细胞因子的表达会有所不同。我们使用细胞因子人类磁性 25-Plex Panel(Invitrogen,Waltham,MA,USA)分析了 136 名生长发育中的骨骼发育不良患者体内的细胞因子水平,并与 275 名健康儿科对照组受试者进行了比较。我们重点研究了九个发育不良队列中 12 种细胞因子的表达情况。最常见的骨骼发育不良诊断为:软骨发育不全(58 例)、成骨不全(19 例)、II 型胶原病(11 例)、多发性骺发育不良(MED:9 例)、灾难性发育不良(8 例)、变性发育不良(8 例)和小头骨发育不良性原始侏儒症 II 型(MOPDII:8 例)。在 108 项具体观察结果中,45 项(41.7%)表明对照组与骨骼发育不良患者之间存在统计学意义上的表达差异。在分析的 12 种细胞因子中,有 4 种细胞因子在所有发育不良队列中的表达均高于对照组水平(白细胞介素 12 [IL-12]、IL-13、干扰素 γ 诱导蛋白 10 kDa [IP-10]、活化调节、正常 T 细胞表达和分泌 [RANTES]),有两种细胞因子在所有发育不良队列中的表达均低于对照组水平(单核细胞趋化蛋白 1 [MCP-1]、巨噬细胞炎症蛋白-1β [MIP-1β])。MOPDII 的过表达水平最高,IP-10 的表达水平增加了 3.8 倍(p < 0.0001)。具有统计学意义的最低表达水平出现在 II 型胶原病中,MCP-1 的表达水平降低了 0.43 倍(p < 0.005)。我们希望通过这些数据为发育不良研究的未来方向奠定基础,从而加深我们对这些复杂信号通路的理解。展望未来,验证细胞因子表达的这些早期趋势,并将观察到的变化与发育不良的进展趋势联系起来,可能会为临床生物标记物甚至新疗法提供新的候选者。© 2023 作者。JBMR Plus 由 Wiley Periodicals LLC.代表美国骨矿研究学会出版。
{"title":"Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia","authors":"David A. O'Connell,&nbsp;Ricki S. Carroll,&nbsp;Angela L. Duker,&nbsp;Andrea J. Schelhaas,&nbsp;Marjorie M. Postell,&nbsp;Paul T. Fawcett,&nbsp;Michael B. Bober","doi":"10.1002/jbm4.10816","DOIUrl":"10.1002/jbm4.10816","url":null,"abstract":"<p>The skeletal dysplasias are a heterogeneous group of genetic conditions caused by abnormalities of growth, development, and maintenance of bone and cartilage. Little is known about the roles that cytokines play in the inflammatory and non-inflammatory pathophysiology of skeletal dysplasia. We sought to test our hypothesis that cytokines would be differentially expressed in children with skeletal dysplasia as compared to typically growing controls. Cytokine levels were analyzed using the Cytokine Human Magnetic 25-Plex Panel (Invitrogen, Waltham, MA, USA); 136 growing individuals with skeletal dysplasia and compared to a cohort of 275 healthy pediatric control subjects. We focused on the expression of 12 cytokines across nine dysplasia cohorts. The most common skeletal dysplasia diagnoses were: achondroplasia (58), osteogenesis imperfecta (19), type II collagenopathies (11), multiple epiphyseal dysplasia (MED: 9), diastrophic dysplasia (8), metatropic dysplasia (8), and microcephalic osteodysplastic primordial dwarfism type II (MOPDII: 8). Of the 108 specific observations made, 45 (41.7%) demonstrated statistically significant differences of expression between controls and individuals with skeletal dysplasia. Four of the 12 analyzed cytokines demonstrated elevated expression above control levels in all of the dysplasia cohorts (interleukin 12 [IL-12], IL-13, interferon γ-induced protein 10 kDa [IP-10], regulated on activation, normal T cell expressed and secreted [RANTES]) and two demonstrated expression below control levels across all dysplasia cohorts (monocyte chemoattractant protein 1 [MCP-1], macrophage inflammatory protein-1β [MIP-1β]). The highest levels of overexpression were seen in MOPDII, with expression levels of IP-10 being increased 3.8-fold (<i>p</i> &lt; 0.0001). The lowest statistically significant levels of expressions were in type II collagenopathies, with expression levels of MCP-1 being expressed 0.43-fold lower (<i>p</i> &lt; 0.005). With this data, we hope to lay the groundwork for future directions in dysplasia research that will enhance our understanding of these complex signaling pathways. Looking forward, validating these early trends in cytokine expression, and associating the observed variations with trends in the progression of dysplasia may offer new candidates for clinical biomarkers or even new therapeutics. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10816","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135241086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in Vertebral Bone Density and Paraspinal Muscle Morphology Following Spaceflight and 1 Year Readaptation on Earth 太空飞行和在地球上重新适应 1 年后脊椎骨密度和脊柱旁肌肉形态的变化
IF 3.8 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-11-08 DOI: 10.1002/jbm4.10810
Jennifer C. Coulombe, Fjola Johannesdottir, Katelyn A. Burkhart, Henriette Brummer, Brett T. Allaire, Mary L. Bouxsein

Astronauts have an increased risk of back pain and disc herniation upon returning to Earth. Thus, it is imperative to understand the effects of spaceflight and readaptation to gravity on the musculoskeletal tissues of the spine. Here we investigated whether ~6 months of spaceflight led to regional differences in bone loss within the vertebral body. Additionally, we evaluated the relationships between vertebral bone density and paraspinal muscle morphology before flight, after flight, and after readaptation on Earth. We measured vertebral trabecular bone mineral density (Tb.BMD), paraspinal muscle cross-sectional area (CSA), and muscle density in 17 astronauts using computed tomography (CT) images of the lumbar spine obtained before flight (before flight, n = 17), after flight (spaceflight, n = 17), and ~12 months of readaptation to gravitational loading on Earth (follow-up, n = 15). Spaceflight-induced declines in Tb.BMD were greater in the superior region of the vertebral body (−6.7%) than the inferior (−3.1%, p = 0.052 versus superior region) and transverse regions (−4.3%, p = 0.057 versus superior region). After a year of readaptation to Earth's gravity, Tb.BMD in the transverse region remained significantly below preflight levels (−4.66%, p = 0.0094). Paraspinal muscle CSA and muscle density declined −1.0% (p = 0.005) and −0.83% (p = 0.001) per month of spaceflight, respectively. Ultimately, bone loss in the superior vertebral body, along with fatty infiltration of paraspinal muscles and incomplete recovery even after a year of readaptation on Earth, may contribute to spinal pathology in long-duration astronauts. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

宇航员返回地球后患背痛和椎间盘突出症的风险会增加。因此,了解太空飞行和重新适应重力对脊柱肌肉骨骼组织的影响势在必行。在此,我们研究了约 6 个月的太空飞行是否会导致椎体内骨质流失的区域性差异。此外,我们还评估了飞行前、飞行后和在地球上重新适应后脊椎骨密度与脊柱旁肌肉形态之间的关系。我们使用飞行前(飞行前,n = 17)、飞行后(太空飞行,n = 17)和在地球上重新适应重力负荷约 12 个月后(随访,n = 15)获得的腰椎计算机断层扫描(CT)图像,测量了 17 名宇航员的椎体骨小梁骨矿物质密度(Tb.BMD)、脊柱旁肌肉横截面积(CSA)和肌肉密度。太空飞行引起的椎体上部 Tb.BMD 下降率(-6.7%)大于下部(-3.1%,与上部相比 p = 0.052)和横向区域(-4.3%,与上部相比 p = 0.057)。在重新适应地球重力一年后,横向区域的 Tb.BMD 仍明显低于飞行前水平(-4.66%,p = 0.0094)。每飞行一个月,脊柱旁肌肉CSA和肌肉密度分别下降-1.0%(p = 0.005)和-0.83%(p = 0.001)。最终,椎体上部的骨质流失,加上脊柱旁肌肉的脂肪浸润以及在地球上重新适应一年后仍未完全恢复,可能会导致长期宇航员的脊柱病变。© 2023 作者。JBMR Plus 由 Wiley Periodicals LLC 代表美国骨矿研究学会出版。
{"title":"Changes in Vertebral Bone Density and Paraspinal Muscle Morphology Following Spaceflight and 1 Year Readaptation on Earth","authors":"Jennifer C. Coulombe,&nbsp;Fjola Johannesdottir,&nbsp;Katelyn A. Burkhart,&nbsp;Henriette Brummer,&nbsp;Brett T. Allaire,&nbsp;Mary L. Bouxsein","doi":"10.1002/jbm4.10810","DOIUrl":"10.1002/jbm4.10810","url":null,"abstract":"<p>Astronauts have an increased risk of back pain and disc herniation upon returning to Earth. Thus, it is imperative to understand the effects of spaceflight and readaptation to gravity on the musculoskeletal tissues of the spine. Here we investigated whether ~6 months of spaceflight led to regional differences in bone loss within the vertebral body. Additionally, we evaluated the relationships between vertebral bone density and paraspinal muscle morphology before flight, after flight, and after readaptation on Earth. We measured vertebral trabecular bone mineral density (Tb.BMD), paraspinal muscle cross-sectional area (CSA), and muscle density in 17 astronauts using computed tomography (CT) images of the lumbar spine obtained before flight (before flight, <i>n</i> = 17), after flight (spaceflight, <i>n</i> = 17), and ~12 months of readaptation to gravitational loading on Earth (follow-up, <i>n</i> = 15). Spaceflight-induced declines in Tb.BMD were greater in the superior region of the vertebral body (−6.7%) than the inferior (−3.1%, <i>p</i> = 0.052 versus superior region) and transverse regions (−4.3%, <i>p</i> = 0.057 versus superior region). After a year of readaptation to Earth's gravity, Tb.BMD in the transverse region remained significantly below preflight levels (−4.66%, <i>p</i> = 0.0094). Paraspinal muscle CSA and muscle density declined −1.0% (<i>p</i> = 0.005) and −0.83% (<i>p</i> = 0.001) per month of spaceflight, respectively. Ultimately, bone loss in the superior vertebral body, along with fatty infiltration of paraspinal muscles and incomplete recovery even after a year of readaptation on Earth, may contribute to spinal pathology in long-duration astronauts. © 2023 The Authors. <i>JBMR Plus</i> published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.</p>","PeriodicalId":14611,"journal":{"name":"JBMR Plus","volume":"7 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2023-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://asbmr.onlinelibrary.wiley.com/doi/epdf/10.1002/jbm4.10810","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135341669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JBMR Plus
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1